Discontinued — last reported Q3 '22
Intuitive Surgical Acquisitions increased by 4059.1% to $528.20M in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 12.4% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $11.80M | -$200.00K | $1.20M | $0.00 | $7.30M | -$200.00K | $1.80M | $250.00K | $250.00K | $250.00K | $250.00K | $0.00 | $1.20M | $0.00 | $12.70M | $528.20M |
| QoQ Change | — | — | — | — | — | -101.7% | +700.0% | -100.0% | — | -102.7% | >999% | -86.1% | +0.0% | +0.0% | +0.0% | -100.0% | — | -100.0% | — | >999% |
| YoY Change | — | — | — | — | — | — | — | — | -38.1% | +0.0% | +50.0% | — | -96.6% | +225.0% | -86.1% | -100.0% | +380.0% | -100.0% | >999% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.